Product Name | vigabatrin |
Synonyms | 4-Aminohex-5-enoic acid;4-Amino-5-hexenoic acid;(±)-Vigabatrin;(S)-4-aminohex-5-enoic acid;VIGABATRIN;Vigabatrin solution;gamma-Vinyl-GABA;60643-86-9;Vigabatrine;.gamma.-Vinyl-GABA;DivK1c_006760;-Vinyl-GABA;KBio3_002973;(1)-4-Aminohex-5-enoic acid;Spectrum3_001825;FT-0675811;VIGABATRIN, (+/-)-;.gamma.-Vinyl-.gamma.-aminobutyric acid;Prestwick1_000501;DTXSID4041153;(R,S)-4-Amino-5-hexenoic acid;DTXCID2021153;AS-11778;V 8261;NCGC00016087-22;Z1255431434;VINYL GAMMA-AMINOBUTYRIC ACID;CHEBI:63638;SR-01000075653-6;KBioSS_000848;NCGC00016087-09;AMY6474;HMS1569F03;Vigabatrina [Spanish];RMI 71754;DB01080;(?)-gamma-Vinyl GABA;NCGC00024802-04;SPBio_002342;VIGABATRIN [VANDF];( inverted question mark)-gamma-Vinyl GABA;Q421663;NCGC00024802-03;KBio2_003416;NCGC00024802-06;Tox21_110301;Vigabatrin, European Pharmacopoeia (EP) Reference Standard;Vigabatrinum [Latin];SBI-0051243.P003;VIGABATRIN [USP MONOGRAPH];NCGC00016087-08;SpecPlus_000664;(+/-)-4-aminohex-5-enoic acid;A853593;S(+)-4-AMINOHEXENOICACID;UNII-GR120KRT6K;4-Amino-hex-5-enoic acid;BDBM50118886;NCGC00016087-05;Sabril (TN);CPP109;EINECS 270-929-6;(+/-)-?-Vinyl GABA;(+/-)-4-Aminohexenoic acid;CPP 109;CS-0791;CAS-68506-86-5;C07500;KBio2_000848;Prestwick_837;BPBio1_000465;BSPBio_003469;4-Aminohexenoic acid;VIGABATRIN [ORANGE BOOK];Kigabeq;5-Hexenoic acid, 4-amino-;MDL 71,754;.gamma.-vinyl GABA;Sabrilex;KBio2_005984;SY263247;SR-01000075653-1;BCP16220;RMI-71890;Lopac0_001277;KBio1_001704;NS00000678;Spectrum_000368;VIGABATRIN [MART.];Q-201924;CHEMBL89598;Sabril;rac-Vigabatrin;MDL 71754;BPBio1_000925;NCGC00016087-03;MDL-71754;C6H11NO2;SPECTRUM1502036;(y)-gamma-Vinyl GABA;SR-01000075653-4;NCGC00016087-07;(+/-)-gamma-Vinyl GABA;gamma-Vinyl GABA;VIGABATRIN [MI];SDCCGSBI-0051243.P004;D00535;gamma-Vinyl-gamma-Aminobutyric Acid;FT-0700968;NCGC00016087-11;Vinyl .gamma.-aminobutyric Acid;Prestwick2_000501;SCHEMBL26714;CPP-109;NCGC00024802-02;(+-)-gamma-Vinyl GABA;gamma Vinyl GABA;NCGC00261962-01;AB00053309;FT-0675812;Vigabatrine [French];Tox21_501277;HY-15399;EN300-245587;BSPBio_000421;4-amino-5-hexenoicacid;4-aminohex-5-enoic acid/S(+)-Gamma-VIGABATRIN;vigabatrin;(+/-)-gamma-Vinyl-GABA;Vigabatrinum;HMS2096F03;EU-0101277;Vigabatrin [INN];gamma-Vinyl GABA; 4-Amino-5-hexenoic acid;VIGABATRIN [WHO-DD];BRD-A07893380-001-01-6;Vigabatrina;GTPL4821;AKOS015854596;LP01277;NCGC00024802-05;NCGC00016087-06;Prestwick0_000501;Vigabatrin, United States Pharmacopeia (USP) Reference Standard;HMS2094M21;VIGABATRIN [USP-RS];(A+/-)-gamma-Vinyl GABA;HMS3263P16;Prestwick3_000501;VIGABATRIN [USAN];Biomol-NT_000247;4-aminohex-5-enoic acid;SR-01000075653;68506-86-5;VIGABATRIN [EP MONOGRAPH];M071754;(+/-)-Vigabatrin;MFCD00274577;HSDB 8395;HB0868;Vigabatrin [USAN:INN:BAN];Vigabatrin (JAN/USP/INN);Hexenoic acid, 4-amino;CCG-205350;GVG;RMI-71754;GR120KRT6K;VIGABATRIN [JAN];MFCD00274076;NCGC00016087-04;AB00053309_04 |
Catalog No. | A-3402 |
CAS No. | 60643-86-9 |
Molecular Formula | C6H11NO2 |
Molecular Weight | 129.15704 |
Smile Code | C=CC(CCC(=O)O)N |
InChI | |
EINECS | 200-659-6 |
Density | |
Melting point | |
Boiling point | |
Refractive index | |
Water solubility | |
Hazard Symbols | |
Risk Codes | |
Safety Description |